Compound ID | 2603
Synonym(s): Q-35
Class: Fluoroquinolone
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | DNA synthesis inhibitor. Inhibits DNA gyrase and topoisomerase IV enzymes |
| Target Pathogen: | For use against urinary (approved) and respiratory tract infections |
| Description: | Synthetic compound; a fourth generation fluoroquinolone |
| Institute where first reported: | Choongwae Pharma (Korea) |
| Year first mentioned: | 2005 |
| Highest developmental phase: | Approved in Korea |
| Development status: | Approved |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/65958 |
| Guide to Pharmacology: | balofloxacin |
| Citation: | https://www.sciencedirect.com/science/article/pii/S0731708518313025 |